JP2015523339A5 - - Google Patents

Download PDF

Info

Publication number
JP2015523339A5
JP2015523339A5 JP2015514446A JP2015514446A JP2015523339A5 JP 2015523339 A5 JP2015523339 A5 JP 2015523339A5 JP 2015514446 A JP2015514446 A JP 2015514446A JP 2015514446 A JP2015514446 A JP 2015514446A JP 2015523339 A5 JP2015523339 A5 JP 2015523339A5
Authority
JP
Japan
Prior art keywords
alkyl
group
cycloalkyl
atoms
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015514446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015523339A (ja
JP6163695B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/060844 external-priority patent/WO2013178575A1/en
Publication of JP2015523339A publication Critical patent/JP2015523339A/ja
Publication of JP2015523339A5 publication Critical patent/JP2015523339A5/ja
Application granted granted Critical
Publication of JP6163695B2 publication Critical patent/JP6163695B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015514446A 2012-05-30 2013-05-27 新しいインダニルオキシフェニルシクロプロパンカルボン酸 Expired - Fee Related JP6163695B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12170057 2012-05-30
EP12170057.9 2012-05-30
PCT/EP2013/060844 WO2013178575A1 (en) 2012-05-30 2013-05-27 New indanyloxyphenylcyclopropanecarb oxylic acids

Publications (3)

Publication Number Publication Date
JP2015523339A JP2015523339A (ja) 2015-08-13
JP2015523339A5 true JP2015523339A5 (enExample) 2016-07-21
JP6163695B2 JP6163695B2 (ja) 2017-07-19

Family

ID=48536855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015514446A Expired - Fee Related JP6163695B2 (ja) 2012-05-30 2013-05-27 新しいインダニルオキシフェニルシクロプロパンカルボン酸

Country Status (4)

Country Link
US (1) US8633182B2 (enExample)
EP (1) EP2855419B1 (enExample)
JP (1) JP6163695B2 (enExample)
WO (1) WO2013178575A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016019587A1 (en) 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. [7, 6]-fused bicyclic antidiabetic compounds
WO2016022446A1 (en) 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. [5,6]-fused bicyclic antidiabetic compounds
US10662171B2 (en) 2014-08-08 2020-05-26 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
WO2016022742A1 (en) 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
KR102431436B1 (ko) 2014-08-29 2022-08-10 테스 파마 에스.알.엘. α-아미노-β-카복시뮤콘산 세미알데히드 데카복실라제의 억제제
JP6816107B2 (ja) * 2015-08-07 2021-01-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インダニルアミノピリジルシクロプロパンカルボン酸、医薬組成物及びこれらの使用
CN107216317B (zh) * 2016-03-21 2020-04-07 上海医药工业研究院 一种阿法替尼中间体的制备方法
WO2018077699A1 (en) 2016-10-25 2018-05-03 Boehringer Ingelheim International Gmbh Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
JP7008704B2 (ja) * 2016-11-28 2022-01-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インダニルアミノピリジルシクロプロパンカルボン酸、その医薬組成物及び使用
KR102007633B1 (ko) 2016-12-15 2019-08-06 일동제약(주) 신규 페닐 프로피온 산 유도체 및 이의 용도
US10919859B2 (en) 2017-01-26 2021-02-16 Boehringer Ingelheim International Gmbh Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
JP6968181B2 (ja) * 2017-01-26 2021-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インダニルアミノピラジニルシクロプロパンカルボン酸、その医薬組成物及び使用
US10793530B2 (en) 2017-01-26 2020-10-06 Boehringer Ingelheim International Gmbh Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
CN110198928B (zh) * 2017-01-26 2023-08-29 勃林格殷格翰国际有限公司 苄氧基吡啶基环丙烷甲酸、其药物组合物和用途
WO2018138030A1 (en) * 2017-01-26 2018-08-02 Boehringer Ingelheim International Gmbh Benzyloxypyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
JP7049353B2 (ja) 2017-02-08 2022-04-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病の治療のためのインダニルアミノアザジヒドロベンゾフラニル酢酸、医薬組成物
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
CR20200347A (es) 2018-02-13 2020-09-23 Gilead Sciences Inc Inhibidores pd-1/pd-l1
US12083118B2 (en) 2018-03-29 2024-09-10 Arbutus Biopharma Corporation Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same
TWI712412B (zh) 2018-04-19 2020-12-11 美商基利科學股份有限公司 Pd‐1/pd‐l1抑制劑
SG11202012425QA (en) 2018-07-13 2021-01-28 Gilead Sciences Inc Pd-1/pd-l1 inhibitors
WO2020086556A1 (en) 2018-10-24 2020-04-30 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
KR20220150270A (ko) 2019-10-07 2022-11-10 칼리오페, 인크. Gpr119 효능제
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
WO2021236617A1 (en) 2020-05-19 2021-11-25 Kallyope, Inc. Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US628476A (en) 1898-03-18 1899-07-11 Joseph Howard Kirk Junction of cycle, motor-car, or other frames, &c.
AU2001235804A1 (en) 2000-03-06 2001-09-17 Astrazeneca Ab Therapy
US7569570B2 (en) 2002-01-30 2009-08-04 Takeda Pharmaceutical Company Limited Thienopyrimidines, process for preparing the same and use thereof
CA2505322A1 (en) 2002-11-08 2004-05-21 Takeda Pharmaceutical Company Limited Receptor function regulator
US7834013B2 (en) * 2003-11-19 2010-11-16 Glaxosmithkline Llc Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40
WO2005051373A1 (ja) * 2003-11-26 2005-06-09 Takeda Pharmaceutical Company Limited 受容体機能調節剤
AU2004309271A1 (en) 2003-12-25 2005-07-14 Takeda Pharmaceutical Company Limited 3-(4-benzyloxyphenyl)propanoic acid derivatives
JP4875978B2 (ja) 2004-03-15 2012-02-15 武田薬品工業株式会社 アミノフェニルプロパン酸誘導体
DE102004017930A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
PE20061127A1 (es) 2005-02-15 2006-10-21 Glaxo Group Ltd Derivados de propanosulfonamida que potencian el receptor de glutamato
EP1866278A1 (en) 2005-03-28 2007-12-19 Pfizer, Inc. Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
CN101198590B (zh) 2005-08-24 2012-05-09 卫材R&D管理有限公司 吡啶衍生物及嘧啶衍生物（3）
EP1924546A1 (en) 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
WO2007104717A1 (en) 2006-03-15 2007-09-20 Neurosearch A/S Quinazolinones and their use as potassium channels activators
ES2412384T3 (es) 2006-07-18 2013-07-11 Astellas Pharma Inc. Derivado de aminoindano o sal del mismo
KR20110027657A (ko) * 2008-06-25 2011-03-16 다이이찌 산쿄 가부시키가이샤 카르복실산 화합물
JP2012503595A (ja) * 2008-07-28 2012-02-09 シダンスク ユニバーシティ 代謝病の治療用の化合物
WO2010051819A1 (en) 2008-11-10 2010-05-14 Neurosearch A/S Novel 2,3-diamino-quinazolinone derivatives and their medical use
CA2747801A1 (en) 2009-01-22 2010-07-29 Raqualia Pharma Inc. N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
US8389580B2 (en) * 2009-06-02 2013-03-05 Duke University Arylcyclopropylamines and methods of use
WO2010143733A1 (en) * 2009-06-09 2010-12-16 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011103189A1 (en) 2010-02-16 2011-08-25 Uwm Research Foundation, Inc. Methods of reducing virulence in bacteria
UY33229A (es) 2010-02-19 2011-09-30 Boehringer Ingelheim Int Derivados de piridina tricíclicos, medicamentos que contienen tales compuestos, su uso y proceso pa ra su preparación
RU2627703C2 (ru) * 2010-07-23 2017-08-10 Конекшис Лайф Сайенсиз Пвт. Лтд. Агонисты gpr40
JP5809157B2 (ja) * 2010-10-08 2015-11-10 持田製薬株式会社 環状アミド誘導体

Similar Documents

Publication Publication Date Title
JP2015523339A5 (enExample)
JP2013508279A5 (enExample)
JP2012521429A5 (enExample)
JP2018535963A5 (enExample)
JP2007523155A5 (enExample)
JP2013505946A5 (enExample)
JP6709205B2 (ja) 持続時間が超短期、短期、または中期の非対称性逆転可能神経筋遮断物質
RU2015107803A (ru) Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания
JP2013512277A5 (enExample)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2012521428A5 (enExample)
JP2011504903A5 (enExample)
JP2011509309A5 (enExample)
JP2022522694A5 (enExample)
JP2016508506A5 (enExample)
RU2008152763A (ru) Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии
JP2017525699A5 (enExample)
JP2007507494A5 (enExample)
RU2008107733A (ru) Ингибиторы gsk-3
JP2019520344A5 (enExample)
WO2019244000A1 (en) Phenyl and pyridinyl substituted imidazoles as modulators of roryt
JP2020517619A5 (enExample)
JP2015502371A5 (enExample)
IL169478A (en) Thiophene carboxamides as inhibitors of the enzyme ikk - 2
US11130740B2 (en) Substituted 2,3-dihydro-1H-indene analogs and methods using same